Literature DB >> 23158179

Anaplastic thyroid cancer: rare, fatal, and neglected.

Electron Kebebew1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23158179     DOI： 10.1016/j.surg.2012.08.059

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  15 in total

Review 1.  Novel treatments for anaplastic thyroid carcinoma.

Authors:  Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Ilaria Ruffilli; Concettina La Motta; Sabrina Rosaria Paparo; Armando Patrizio; Roberto Vita; Salvatore Benvenga; Gabriele Materazzi; Poupak Fallahi; Alessandro Antonelli
Journal:  Gland Surg       Date:  2020-01

2.  Targeting TGF-β1 suppresses survival of and invasion by anaplastic thyroid carcinoma cells.

Authors:  Wenhai Sun; Yanyan Xu; Cheng Zhao; Fengyun Hao; Dong Chen; Jinping Guan; Kejun Zhang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 3.  Management of anaplastic thyroid cancer.

Authors:  Xavier M Keutgen; Samira M Sadowski; Electron Kebebew
Journal:  Gland Surg       Date:  2015-02

4.  Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.

Authors:  Naris Nilubol; ZiQiang Yuan; Giulio F Paciotti; Lawrence Tamarkin; Carmen Sanchez; Kelli Gaskins; Esther M Freedman; Shugeng Cao; Jielu Zhao; David G I Kingston; Steven K Libutti; Electron Kebebew
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

5.  Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.

Authors:  Lisa Zhang; Yaqin Zhang; Amit Mehta; Myriem Boufraqech; Sean Davis; Jing Wang; Ze Tian; Zhiya Yu; Matthew B Boxer; Jeffrey A Kiefer; John A Copland; Robert C Smallridge; Zhuyin Li; Min Shen; Electron Kebebew
Journal:  Oncotarget       Date:  2015-04-20

6.  Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.

Authors:  Samira M Sadowski; Myriem Boufraqech; Lisa Zhang; Amit Mehta; Payal Kapur; Yaqin Zhang; Zhuyin Li; Min Shen; Electron Kebebew
Journal:  Oncotarget       Date:  2015-07-20

7.  Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling.

Authors:  Qiang Yin; Shan Liu; Anbing Dong; Xiufang Mi; Fengyun Hao; Kejun Zhang
Journal:  Med Sci Monit       Date:  2016-06-30

8.  Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal Protein.

Authors:  Dehuang Guo; Qinqin Xu; Sarabjot Pabla; John Koomen; Paul Biddinger; Ashok Sharma; Simarjot Pabla; Rafal Pacholczyk; Chien-Chung Chang; Kevin Friedrich; Kamran Mohammed; Robert C Smallridge; John A Copland; Jin-Xiong She; Paul M Weinberger
Journal:  Int J Mol Sci       Date:  2018-02-14       Impact factor: 5.923

9.  CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer.

Authors:  Li-Chi Huang; Ka-Wai Tam; Wei-Ni Liu; Chun-Yu Lin; Kai-Wen Hsu; Wen-Shyang Hsieh; Wei-Ming Chi; Ai-Wei Lee; Jinn-Moon Yang; Ching-Ling Lin; Chia-Hwa Lee
Journal:  Dis Markers       Date:  2018-04-12       Impact factor: 3.434

10.  Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer.

Authors:  Lisa Zhang; Myriem Boufraqech; Ross Lake; Electron Kebebew
Journal:  Oncotarget       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.